Collectively, these findings highlight PPARα-mediated LD-mitochondrial dynamics as a pivotal link between CIH and PD pathogenesis and underscore its potential as a clinically actionable target for alleviating PD vulnerability in patients with OSA. Here, PPARA is linked to Parkinson disease.